| Literature DB >> 29952137 |
Kayla L Moses1,2, McKayla Seymour3, Arij Beshish1, Kim R Baker4, David F Pegelow1, Luke J Lamers5, Marlowe W Eldridge1,2,6, Melissa L Bates3,7,8.
Abstract
A patent foramen ovale (PFO) is linked to increased risk of decompression illness in divers. One theory is that venous gas emboli crossing the PFO can be minimized by avoiding lifting, straining and Valsalva maneuvers. Alternatively, we hypothesized that mild increases in external inspiratory and expiratory resistance, similar to that provided by a SCUBA regulator, recruit the PFO. Nine healthy adults with a Valsalva-proven PFO completed three randomized trials (inspiratory, expiratory, and combined external loading) with six levels of increasing external resistance (2-20 cmH2 O/L/sec). An agitated saline contrast echocardiogram was performed at each level to determine foramen ovale patency. Contrary to our hypothesis, there was no relationship between the number of subjects recruiting their PFO and the level of external resistance. In fact, at least 50% of participants recruited their PFO during 14 of 18 trials and there was no difference between the combined inspiratory, expiratory, or combined external resistance trials (P > 0.05). We further examined the relationship between PFO recruitment and intrathoracic pressure, estimated from esophageal pressure. Esophageal pressure was not different between participants with and without a recruited PFO. Intrasubject variability was the most important predictor of PFO patency, suggesting that some individuals are more likely to recruit their PFO in the face of even mild external resistance. Right-to-left bubble passage through the PFO occurs in conditions that are physiologically relevant to divers. Transthoracic echocardiography with mild external breathing resistance may be a tool to identify divers that are at risk of PFO-related decompression illness.Entities:
Keywords: Airway resistance; diving; patent foramen ovale; shunt; stroke; work of breathing
Mesh:
Year: 2018 PMID: 29952137 PMCID: PMC6021277 DOI: 10.14814/phy2.13719
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Anthropometric and pulmonary function data (n = 3 male, n = 6 female)
| Age, yr | 25 ± 5 |
| Height, cm | 175.3 ± 7.6 |
| Weight, kg | 76.2 ± 11.1 |
| BMI, kg/m2 | 24.8 ± 3.9 |
| FVC, L | 5.1 ± 1.3 |
| FEV1, L | 4.1 ± 1.3 |
| FEV1, % predicted | 107.0 ± 16.3 |
| FEV1/FVC, % | 79.2 ± 9.2 |
Values are mean ± SD. yr, years; BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec.
Figure 1Percent frequency of patent foramen ovale (PFO) recruitment at each level (0–20 cmH2O) of inspiratory, expiratory, and combined external resistance. No subject recruited their PFO with 0 cmH2O external resistance. At least 50% of participants recruited their PFO during 14 of the remaining 18 stages (2–20 cmH2O).
Effect of external breathing resistance on cardiorespiratory variables
| Baseline | 2 cmH2O/L/sec | 4 cmH2O/L/sec | 8 cmH2O/L/sec | 12 cmH2O/L/sec | 16 cmH2O/L/sec | 20 cmH2O/L/sec | |
|---|---|---|---|---|---|---|---|
| External inspiratory resistance | |||||||
| Minute ventilation (L/min) | 11.0 ± 3.0 | 9.8 ± 3.1 | 10.9 ± 2.7 | 15.8 ± 17.1 | 11.4 ± 3.5 | 10.3 ± 3.2 | 10.4 ± 3.0 |
| Frequency (breaths/min) | 14 ± 4 | 13 ± 3 | 13 ± 3 | 12 ± 3 | 13 ± 4 | 12 ± 4 | 13 ± 4 |
| Expiratory time (%) | 54 ± 6 | 48 ± 5 | 45 ± 7 | 45 ± 6 | 47 ± 6 | 43 ± 8 | 46 ± 8 |
| SpO2 (%) | 97 ± 2 | 97 ± 1 | 97 ± 2 | 97 ± 2 | 98 ± 1 | 98 ± 1 | 97 ± 1 |
| Heart rate (beats/min) | 63 ± 10 | 62 ± 11 | 62 ± 8 | 61 ± 8 | 61 ± 9 | 62 ± 11 | 62 ± 9 |
| ETCO2 (mmHg) | 35 ± 6 | 35 ± 6 | 35 ± 6 | 35 ± 6 | 35 ± 6 | 36 ± 5 | 36 ± 5 |
| VO2 (L/min) | 0.52 ± 0.3 | 0.54 ± 0.3 | 0.54 ± 0.3 | 0.61 ± 0.3 | 0.54 ± 0.3 | 0.56 ± 0.3 | 0.52 ± 0.3 |
| External expiratory resistance | |||||||
| Minute ventilation (L/min) | 11.0 ± 3.3 | 9.0 ± 4.3 | 9.5 ± 3.4 | 9.1 ± 3.6 | 9.5 ± 5.2 | 9.1 ± 4.2 | 9.2 ± 4.67 |
| Frequency (breaths/min) | 15 ± 3 | 12 ± 3 | 13 ± 3 | 13 ± 3 | 12 ± 3 | 11 ± 3 | 11 ± 3 |
| Expiratory time (%) | 50 ± 7 | 51 ± 5 | 56 ± 5 | 52 ± 5 | 51 ± 7 | 55 ± 5 | 55 ± 4 |
| SpO2 (%) | 97 ± 1 | 98 ± 2 | 97 ± 1 | 97 ± 2 | 97 ± 1 | 98 ± 1 | 98 ± 1 |
| Heart rate (beats/min) | 64 ± 17 | 61 ± 10 | 59 ± 9 | 61 ± 10 | 61 ± 10 | 61 ± 10 | 62 ± 11 |
| ETCO2 (mmHg) | 37 ± 3 | 30 ± 4 | 33 ± 4 | 33 ± 4 | 33 ± 4 | 33 ± 4 | 34 ± 4 |
| VO2 (L/min) | 0.52 ± 0.3 | 0.51 ± 0.3 | 0.48 ± 0.3 | 0.51 ± 0.3 | 0.49 ± 0.3 | 0.49 ± 0.3 | 0.47 ± 0.3 |
| Combined external resistance | |||||||
| Minute ventilation (L/min) | 9.7 ± 2.1 | 10.8 ± 3.7 | 9.2 ± 3.3 | 9.8 ± 2.4 | 9.6 ± 2.8 | 10.0 ± 2.1 | 9.4 ± 2.9 |
| Frequency (breaths/min) | 13 ± 2 | 13 ± 3 | 13 ± 3 | 11 ± 3 | 11 ± 3 | 11 ± 3 | 10 ± 4 |
| Expiratory time (%) | 50 ± 9 | 46 ± 5 | 51 ± 6 | 51 ± 6 | 51 ± 6 | 48 ± 7 | 49 ± 8 |
| SpO2 (%) | 97 ± 2 | 97 ± 2 | 97 ± 1 | 97 ± 1 | 97 ± 1 | 97 ± 1 | 97 ± 1 |
| Heart rate (beats/min) | 63 ± 12 | 63 ± 10 | 61 ± 10 | 65 ± 1 | 60 ± 8 | 63 ± 9 | 60 ± 17 |
| ETCO2 (mmHg) | 33 ± 13 | 31 ± 13 | 31 ± 12 | 32 ± 13 | 32 ± 13 | 35 ± 13 | 34 ± 13 |
| VO2 (L/min) | 0.52 ± 0.3 | 0.47 ± 0.6 | 0.44 ± 0.9 | 0.44 ± 0.6 | 0.44 ± 0.6 | 0.43 ± 0.6 | 0.40 ± 0.6 |
Values are mean ± SD. SpO2, arterial oxygen saturation; ETCO2, end tidal CO2; VO2, volume of oxygen uptake.
Figure 2Top: Relationship between peak inspiratory and expiratory esophageal pressure and external resistance. Peak inspiratory pressure generally fell and expiratory pressure increased as a function of Increasing external resistance (**P < 0.05). Bottom: The peak inspiratory‐expiratory pressure difference was not difference between individuals with a recruited PFO (PFO +) and a closed PFO (PFO −). There were also no differences in peak inspiratory and expiratory pressures between PFO + and PFO − individuals (not shown).
Significance of relationship (P‐value) between the changes in esophageal pressure and external breathing resistance
| Peak expiratory pressure | Peak inspiratory pressure | Expiratory‐inspiratory pressure difference | |
|---|---|---|---|
| External inspiratory resistance | 0.013 | 0.001 | <0.001 |
| External expiratory resistance | 0.004 | 0.031 | <0.001 |
| Combined external resistance | 0.068 | <0.001 | <0.001 |
Values are expressed as means ± the standard deviation. Inspiratory PES, peak inspiratory esophageal pressure; expiratory PES, peak expiratory esophageal pressure; HR, heart rate; SpO2, peripheral oxygen saturation;O2, oxygen consumption; E, minute ventilation; f, breathing frequency.
Patent foramen ovale recruitment by stage for inspiratory, expiratory, and combined external resistance trials
| Subject | External inspiratory resistance (cmH2O/L/min) | External expiratory resistance (cmH2O/L/min) | Combined external resistance (cmH2O/L/min) | Overall PFO+ Stages (%) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 2 | 4 | 8 | 12 | 16 | 20 | PFO+ Stages (%) | 0 | 2 | 4 | 8 | 12 | 16 | 20 | PFO+ Stages (%) | 0 | 2 | 4 | 8 | 12 | 16 | 20 | PFO+ Stages (%) | ||
| 1 | 0 | √ | 16 | √ | 16 | 11 | |||||||||||||||||||
| 2 | √ | 16 | √ | 16 | √ | 16 | 17 | ||||||||||||||||||
| 3 | √ | √ | √ | √ | √ | 83 | √ | √ | √ | 50 | 0 | 44 | |||||||||||||
| 4 | √ | 16 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | √ | √ | √ | 100 | 61 | ||||||||
| 5 | √ | √ | √ | √ | 66 | √ | √ | √ | 50 | √ | √ | √ | √ | 66 | 61 | ||||||||||
| 6 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | √ | √ | 83 | √ | √ | √ | √ | √ | 83 | 89 | |||||
| 7 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | 50 | 83 | ||||||
| 8 | √ | √ | √ | √ | 66 | √ | √ | √ | √ | 66 | √ | √ | √ | √ | √ | √ | 100 | 78 | |||||||
| 9 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | √ | √ | √ | 100 | √ | √ | √ | √ | √ | 83 | 94 | ||||
√ indicates that a patent foramen ovale was visualized during that stage.
Figure 3Comparison of the percent of stages with a recruited patent foramen ovale (PFO) between trials where individuals had their PFO closed at 2 cmH2O (closed circles) or open (open circles). Trials where the PFO was open at 2 cmH2O had a greater number of stages with a recruited PFO compared to trials where the PFO was closed (**P < 0.05 from repeated measures ANOVA).